Back Login for AI Analysis

    NRXP (STOCKS)

    NRX Pharmaceuticals, Inc. Common Stock

    $4.008200
    +0.168200 (+4.38%)
    Prev close: $3.840000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Jonathan C. Javitt
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $171.34M
    Employees
    P/E (TTM)
    -3.19
    P/B (TTM)
    -9.88
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    3
    Strong Buy
    7
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Mar 2026 (Q1)
    $-0.04 $0.29 -0.3332 -113.64%
    Dec 2025 (Q4)
    $-0.01 $0.00 -0.0094 -361.54%
    Sep 2025 (Q3)
    $-0.50 $-0.09 -0.4133 -476.70%
    Jun 2025 (Q2)
    $-0.31 $-0.21 -0.1026 -49.47%
    Financial Statements
    TTM (Mar 2026)
    Revenues $2.29M
    Cost Of Revenue $1.14M
    Costs And Expenses $19.41M
    Nonoperating Income/Loss -$7.42M
    Operating Expenses $18.28M
    Selling, General, and Administrative Expenses $13.93M
    Depreciation and Amortization $133.00K
    Research and Development $4.28M
    Operating Income/Loss -$17.12M
    Income/Loss From Continuing Operations After Tax -$24.54M
    Income/Loss From Continuing Operations Before Tax -$30.97M
    Income/Loss From Equity Method Investments $37.00K
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$24.54M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$24.54M
    Net Income/Loss Available To Common Stockholders, Basic -$24.54M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$1.09
    Basic Average Shares 75,010,412
    Assets $11.90M
    Current Assets $7.36M
    Noncurrent Assets $4.54M
    Fixed Assets $259.00K
    Intangible Assets $879.00K
    Other Non-current Assets $3.40M
    Liabilities $25.72M
    Current Liabilities $25.18M
    Accounts Payable $4.40M
    Wages $394.00K
    Other Current Liabilities $20.38M
    Noncurrent Liabilities $543.00K
    Equity -$13.82M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent -$13.82M
    Liabilities And Equity $11.90M
    Net Cash Flow From Operating Activities -$14.93M
    Net Cash Flow From Operating Activities, Continuing -$14.93M
    Net Cash Flow From Investing Activities $1.08M
    Net Cash Flow From Investing Activities, Continuing $1.08M
    Net Cash Flow From Financing Activities $19.12M
    Net Cash Flow From Financing Activities, Continuing $19.12M
    Net Cash Flow $5.27M
    Net Cash Flow, Continuing $5.27M
    Comprehensive Income/Loss -$24.54M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$24.54M
    Other Comprehensive Income/Loss $23.09M